152 related articles for article (PubMed ID: 31648117)
1. Encapsulation of an endostatin peptide in liposomes: Stability, release, and cytotoxicity study.
Rezaei N; Mehrnejad F; Vaezi Z; Sedghi M; Asghari SM; Naderi-Manesh H
Colloids Surf B Biointerfaces; 2020 Jan; 185():110552. PubMed ID: 31648117
[TBL] [Abstract][Full Text] [Related]
2. Engineering of a disulfide loop instead of a Zn binding loop restores the anti-proliferative, anti-angiogenic and anti-tumor activities of the N-terminal fragment of endostatin: Mechanistic and therapeutic insights.
Chamani R; Asghari SM; Alizadeh AM; Eskandari S; Mansouri K; Khodarahmi R; Taghdir M; Heidari Z; Gorji A; Aliakbar A; Ranjbar B; Khajeh K
Vascul Pharmacol; 2015 Sep; 72():73-82. PubMed ID: 26187352
[TBL] [Abstract][Full Text] [Related]
3. Effect of Disulfide Bond Incorporation on the Structure and Activity of Endostatin Peptide.
Ehtesham S; Sariri R; Eidi A; Hosseinkhani S
Biochemistry (Mosc); 2018 Nov; 83(11):1388-1398. PubMed ID: 30482150
[TBL] [Abstract][Full Text] [Related]
4. Controlled release of an endostatin peptide using chitosan nanoparticles.
Ebrahimi Samani S; Seraj Z; Naderimanesh H; Khajeh K; Esmaeili Rastaghi AR; Droudi T; Kolivand P; Kazemi H; Asghari SM
Chem Biol Drug Des; 2017 Sep; 90(3):417-424. PubMed ID: 28165672
[TBL] [Abstract][Full Text] [Related]
5. The antiangiogenic and antitumor activities of the N-terminal fragment of endostatin augmented by Ile/Arg substitution: The overall structure implicated the biological activity.
Chamani R; Asghari SM; Alizadeh AM; Mansouri K; Doroudi T; Kolivand PH; Ghafouri H; Ehtesham S; Rabouti H; Mehrnejad F
Biochim Biophys Acta; 2016 Dec; 1864(12):1765-1774. PubMed ID: 27693049
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibition of angiogenesis and liver tumor growth by administration of an aerosol containing a transferrin-liposome-endostatin complex.
Li X; Fu GF; Fan YR; Shi CF; Liu XJ; Xu GX; Wang JJ
World J Gastroenterol; 2003 Feb; 9(2):262-6. PubMed ID: 12532444
[TBL] [Abstract][Full Text] [Related]
7. Expression of endostatin mediated by a novel non-viral delivery system inhibits human umbilical vein endothelial cells in vitro.
Zhang C; Zhang X; Liu C; Wang J; Liu X; Li H; Wang J; Wu C
Mol Biol Rep; 2010 Apr; 37(4):1755-62. PubMed ID: 19585274
[TBL] [Abstract][Full Text] [Related]
8. A novel tumor-targeted thermosensitive liposomal cerasome used for thermally controlled drug release.
Li S; Yin G; Pu X; Huang Z; Liao X; Chen X
Int J Pharm; 2019 Oct; 570():118660. PubMed ID: 31491484
[TBL] [Abstract][Full Text] [Related]
9. Structural analysis of the N-terminal fragment of the antiangiogenic protein endostatin: a molecular dynamics study.
Torres PH; Sousa GL; Pascutti PG
Proteins; 2011 Sep; 79(9):2684-92. PubMed ID: 21769939
[TBL] [Abstract][Full Text] [Related]
10. Redox-sensitive irinotecan liposomes with active ultra-high loading and enhanced intracellular drug release.
Wang T; He W; Du Y; Wang J; Li X
Colloids Surf B Biointerfaces; 2021 Oct; 206():111967. PubMed ID: 34256270
[TBL] [Abstract][Full Text] [Related]
11. Aptamer-based liposomes improve specific drug loading and release.
Plourde K; Derbali RM; Desrosiers A; Dubath C; Vallée-Bélisle A; Leblond J
J Control Release; 2017 Apr; 251():82-91. PubMed ID: 28238787
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
Haghiralsadat F; Amoabediny G; Helder MN; Naderinezhad S; Sheikhha MH; Forouzanfar T; Zandieh-Doulabi B
Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):169-177. PubMed ID: 28376641
[TBL] [Abstract][Full Text] [Related]
13. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
14. Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models.
Yin X; Chi Y; Guo C; Feng S; Liu J; Sun K; Wu Z
Pharm Res; 2017 Oct; 34(10):2172-2184. PubMed ID: 28726003
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
[TBL] [Abstract][Full Text] [Related]
16. Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity.
Teymouri M; Badiee A; Golmohammadzadeh S; Sadri K; Akhtari J; Mellat M; Nikpoor AR; Jaafari MR
Int J Pharm; 2016 Sep; 511(1):236-244. PubMed ID: 27363937
[TBL] [Abstract][Full Text] [Related]
17. Human endostatin gene transfer, either naked or with liposome, has the same inhibitory effect on growth of mouse liver tumor cells in vivo.
Ma CH; Zhang Y; Wang XY; Gao LF; Liu H; Guo C; Liu SX; Cao YL; Zhang LN; Sun WS
World J Gastroenterol; 2004 Oct; 10(19):2874-7. PubMed ID: 15334690
[TBL] [Abstract][Full Text] [Related]
18. Fusogenic liposomal formulation of sirolimus: improvement of drug anti-proliferative effect on human T-cells.
Valizadeh H; Ghanbarzadeh S; Zakeri-Milani P
Drug Dev Ind Pharm; 2015; 41(9):1558-65. PubMed ID: 25311425
[TBL] [Abstract][Full Text] [Related]
19. Binding of endostatin to phosphatidylserine-containing membranes and formation of amyloid-like fibers.
Zhao H; Jutila A; Nurminen T; Wickström SA; Keski-Oja J; Kinnunen PK
Biochemistry; 2005 Mar; 44(8):2857-63. PubMed ID: 15723529
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel-loaded RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes: Drug release, cytotoxicity, and antitumor efficacy.
Yoon HY; Kwak SS; Jang MH; Kang MH; Sung SW; Kim CH; Kim SR; Yeom DW; Kang MJ; Choi YW
Int J Pharm; 2017 May; 523(1):229-237. PubMed ID: 28341149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
